Jordi Rodon Ahnert

43PUBLICATIONS
444CO-AUTHORS
Molecular targetsPredictive and prognostic markersRadiation therapyAutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (43)

|Jul 13, 2026
Application of a translational research platform to unveil efficacy signals and mechanisms of resistance of FGFR inhibitors in multiple FGFR-altered solid tumors.

|Jun 04, 2026
Convergence of KRAS Mutations and MTAP Loss in Pancreatic Cancer: Genomic Landscape and Clinical Implications.

|Jun 01, 2026
Targeting Fibroblast Activation Protein with [177Lu]Lu-FAP-2286 in Patients with Advanced Solid Tumors in the Phase I LuMIERE Trial.

|May 23, 2026
Safety and Efficacy of HexaBody-DR5/DR5 in Malignant Solid Tumors: Phase 1/2a Results and Translational Insights Into Observed Hepatotoxicity.

|Mar 26, 2026
Comprehensive Genomic and Transcriptomic Analysis to Guide Therapy for Patients with Metastatic Solid Tumors.

Burak Uzunparmak, Fei Su, Amber Johnson

|Jan 09, 2026
MTAP Deletion in Oncogenesis: A Synthetic Lethality Scenario.

Jordi Rodon, Melissa L Johnson, Ben George

Pageof 8

Frequent Collaborators

15 joint publications

Funda Meric-Bernstam

10 joint publications

Siqing Fu

8 joint publications

Timothy Anthony Yap

8 joint publications

David S Hong